Study Protocol
Accepted on 06 Mar 2026
Comparative Efficacy and Safety of Individual Short-Acting versus Long-Acting Granulocyte Colony-Stimulating Factors, Including Biosimilars, for Primary Prophylaxis of Chemotherapy-Induced Myelosuppression in Breast Cancer Patients: A Systematic Review and Network Meta-Analysis Protocol
in Breast Cancer